Indeed, combining an MDM2 antagonist and a CDK4 inhibitor resulted in an antagonistic effect in myxofibrosarcoma (IB114) and leiomyosarcoma (IB136) cells, indicating that the synergistic effect was specific to the DDLPS histological subtype (Fig. 5). This evidence concerns the gene CDK4 and myxofibrosarcoma.